{"transactions":[{"id":2344383,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-08T22:33:48.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":2768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted to the Reporting Person under the Issuer's 2021 Omnibus Incentive Plan.  Each restricted stock award represents the contingent right to receive one share of Common Stock.  The restricted stock awards vest in full on March 4, 2023, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":37806,"source":{"system":"sec-edgar","filing":"0000904454-22-000234","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445422000234/edgar.xml","form_type":"4"}},{"id":2456156,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T22:03:33.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":2093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted to the Reporting Person under the Issuer's 2021 Omnibus Incentive Plan.  Each restricted stock award represents the contingent right to receive one share of Common Stock.  The restricted stock awards vest on February 15, 2022, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":35038,"source":{"system":"sec-edgar","filing":"0000904454-21-000875","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445421000875/edgar.xml","form_type":"4/A","original_submission_date":"2021-03-11"}},{"id":2794549,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T00:51:18.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":2903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted to the Reporting Person under the Issuer's 2021 Omnibus Incentive Plan.  Each restricted stock award represents the contingent right to receive one share of Common Stock.  The restricted stock awards vest on February 15, 2022, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":35848,"source":{"system":"sec-edgar","filing":"0000904454-21-000336","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445421000336/edgar.xml","form_type":"4"}},{"id":3217755,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:29:00.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":5414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted to the Reporting Person under the Issuer's 2012 Omnibus Incentive Plan, as amended and restated.  Each restricted stock award represents the contingent right to receive one share of Common Stock.  The restricted stock awards vest on February 15, 2021, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":32945,"source":{"system":"sec-edgar","filing":"0000904454-20-000286","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445420000286/edgar.xml","form_type":"4"}},{"id":3453511,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:22.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option provided for vesting in four equal annual installments beginning on October 25, 2019."}],"balance_after":0,"derivative":{"exercise_price":14.55,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-043787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043787/doc4.xml","form_type":"4"}},{"id":3453510,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:06:22.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting in four equal annual installments beginning on October 26, 2018."}],"balance_after":0,"derivative":{"exercise_price":10.47,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-043787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043787/doc4.xml","form_type":"4"}},{"id":3453509,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-30T20:06:22.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Company common stock underlying each restricted stock unit (a \"Company RSU\") held by the Reporting Person, whether or not vested. Pursuant to the terms of the Merger Agreement, each Company RSU held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of (i) $48.00 and (ii) the number of shares of Company common stock subject to such Company RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-043787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043787/doc4.xml","form_type":"4"}},{"id":3453508,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-30T20:06:22.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":24297,"price":48,"value":1166256.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-043787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043787/doc4.xml","form_type":"4"}},{"id":3612474,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T22:00:13.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Issuer's 2012 Omnibus Incentive Plan, as amended and restated.  Each restricted stock unit represents the contingent right to receive one share of Common Stock.  The restricted stock units vest on February 15, 2020, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":27531,"source":{"system":"sec-edgar","filing":"0000904454-19-000311","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445419000311/edgar.xml","form_type":"4"}},{"id":3781745,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-10-29T18:10:47.000Z","date":"2018-10-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested and were settled in common stock on October 26, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested and were settled in common stock on October 26, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-004318","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004318/primarydocument.xml","form_type":"4"}},{"id":3781744,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-10-29T18:10:47.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock.  The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock.  The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-004318","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004318/primarydocument.xml","form_type":"4"}},{"id":3781743,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-29T18:10:47.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full on October 25, 2019, subject to continued service on Array's board of directors."}],"balance_after":25000,"derivative":{"exercise_price":14.55,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-004318","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004318/primarydocument.xml","form_type":"4"}},{"id":3781742,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-29T18:10:47.000Z","date":"2018-10-26","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by Array BioPharma Inc. (\"Array\") on October 26, 2017, as a result of the vesting of all such RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by Array BioPharma Inc. (\"Array\") on October 26, 2017, as a result of the vesting of all such RSUs."}],"balance_after":24297,"source":{"system":"sec-edgar","filing":"0001562180-18-004318","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004318/primarydocument.xml","form_type":"4"}},{"id":3809938,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-21T16:18:33.000Z","date":"2018-09-19","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested on October 27, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.95,"expiration_date":"2026-10-27","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-18-004003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004003/primarydocument.xml","form_type":"4"}},{"id":3809937,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-21T16:18:33.000Z","date":"2018-09-19","kind":"sale","acquired":false,"shares":18000,"price":14.7602,"value":265683.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $14.575 to $14.80. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-004003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004003/primarydocument.xml","form_type":"4"}},{"id":3809936,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-21T16:18:33.000Z","date":"2018-09-19","kind":"exercise","acquired":true,"shares":18000,"price":5.95,"value":107100.0,"ownership":{"direct":true},"balance_after":37297,"source":{"system":"sec-edgar","filing":"0001562180-18-004003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004003/primarydocument.xml","form_type":"4"}},{"id":3840468,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-17T16:46:26.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested on October 23, 2014."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2023-10-23","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001562180-18-003682","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003682/primarydocument.xml","form_type":"4"}},{"id":3840467,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-17T16:46:26.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vested on October 27, 2017."}],"balance_after":18000,"derivative":{"exercise_price":5.95,"expiration_date":"2026-10-27","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001562180-18-003682","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003682/primarydocument.xml","form_type":"4"}},{"id":3840466,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T16:46:26.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":21500,"price":13.92,"value":299280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-003682","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003682/primarydocument.xml","form_type":"4"}},{"id":3840465,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T16:46:26.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":14500,"price":5.6,"value":81200.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-003682","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003682/primarydocument.xml","form_type":"4"}},{"id":3840464,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T16:46:26.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":7000,"price":5.95,"value":41650.0,"ownership":{"direct":true},"balance_after":26297,"source":{"system":"sec-edgar","filing":"0001562180-18-003682","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003682/primarydocument.xml","form_type":"4"}},{"id":3864707,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-19T16:26:27.000Z","date":"2018-07-18","kind":"exercise","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested on October 29, 2016."}],"balance_after":0,"derivative":{"exercise_price":5.13,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-18-003345","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003345/primarydocument.xml","form_type":"4"}},{"id":3864706,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-19T16:26:27.000Z","date":"2018-07-18","kind":"exercise","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested on October 23, 2014."}],"balance_after":14500,"derivative":{"exercise_price":5.6,"expiration_date":"2023-10-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001562180-18-003345","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003345/primarydocument.xml","form_type":"4"}},{"id":3864705,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-19T16:26:27.000Z","date":"2018-07-18","kind":"sale","acquired":false,"shares":21500,"price":16.56,"value":356040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $16.43 to $17.03. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-003345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003345/primarydocument.xml","form_type":"4"}},{"id":3864704,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-19T16:26:27.000Z","date":"2018-07-18","kind":"exercise","acquired":true,"shares":11000,"price":5.13,"value":56430.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-003345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003345/primarydocument.xml","form_type":"4"}},{"id":3864703,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-19T16:26:27.000Z","date":"2018-07-18","kind":"exercise","acquired":true,"shares":10500,"price":5.6,"value":58800.0,"ownership":{"direct":true},"balance_after":29797,"source":{"system":"sec-edgar","filing":"0001562180-18-003345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003345/primarydocument.xml","form_type":"4"}},{"id":3886283,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T16:20:33.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested on October 24, 2013."}],"balance_after":0,"derivative":{"exercise_price":4.36,"expiration_date":"2022-10-24","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-18-003075","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003075/primarydocument.xml","form_type":"4"}},{"id":3886282,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T16:20:33.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested on October 29, 2016."}],"balance_after":11000,"derivative":{"exercise_price":5.13,"expiration_date":"2025-10-29","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001562180-18-003075","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003075/primarydocument.xml","form_type":"4"}},{"id":3886281,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T16:20:33.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":21500,"price":19.08,"value":410220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.86 to $19.36. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-003075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003075/primarydocument.xml","form_type":"4"}},{"id":3886280,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T16:20:33.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":14000,"price":5.13,"value":71820.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-003075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003075/primarydocument.xml","form_type":"4"}},{"id":3886279,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T16:20:33.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":7500,"price":4.36,"value":32700.0,"ownership":{"direct":true},"balance_after":26797,"source":{"system":"sec-edgar","filing":"0001562180-18-003075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003075/primarydocument.xml","form_type":"4"}},{"id":3928776,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T16:01:41.000Z","date":"2018-05-16","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested on October 30, 2015."}],"balance_after":0,"derivative":{"exercise_price":3.87,"expiration_date":"2024-10-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-18-030848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919118030848/doc4.xml","form_type":"4"}},{"id":3928775,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T16:01:41.000Z","date":"2018-05-16","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested on October 24, 2013."}],"balance_after":7500,"derivative":{"exercise_price":4.36,"expiration_date":"2022-10-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-030848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919118030848/doc4.xml","form_type":"4"}},{"id":3928774,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T16:01:41.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":21500,"price":15.3609,"value":330259.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $15.30 to $15.43. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001209191-18-030848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919118030848/doc4.xml","form_type":"4"}},{"id":3928773,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T16:01:41.000Z","date":"2018-05-16","kind":"exercise","acquired":true,"shares":9000,"price":3.87,"value":34830.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001209191-18-030848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919118030848/doc4.xml","form_type":"4"}},{"id":3928772,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T16:01:41.000Z","date":"2018-05-16","kind":"exercise","acquired":true,"shares":12500,"price":4.36,"value":54500.0,"ownership":{"direct":true},"balance_after":31797,"source":{"system":"sec-edgar","filing":"0001209191-18-030848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919118030848/doc4.xml","form_type":"4"}},{"id":3961264,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-18T16:38:13.000Z","date":"2018-04-18","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested on October 30, 2015."}],"balance_after":9000,"derivative":{"exercise_price":3.87,"expiration_date":"2024-10-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-18-001907","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001907/primarydocument.xml","form_type":"4"}},{"id":3961263,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-18T16:38:13.000Z","date":"2018-04-18","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three equal annual installments commencing November 4, 2011 and ending November 4, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.51,"expiration_date":"2020-11-04","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001562180-18-001907","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001907/primarydocument.xml","form_type":"4"}},{"id":3961262,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-18T16:38:13.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":21500,"price":15.19,"value":326585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-001907","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001907/primarydocument.xml","form_type":"4"}},{"id":3961261,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-18T16:38:13.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":16000,"price":3.87,"value":61920.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-001907","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001907/primarydocument.xml","form_type":"4"}},{"id":3961260,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-18T16:38:13.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":5500,"price":3.51,"value":19305.0,"ownership":{"direct":true},"balance_after":24797,"source":{"system":"sec-edgar","filing":"0001562180-18-001907","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001907/primarydocument.xml","form_type":"4"}},{"id":3986560,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-21T17:11:17.000Z","date":"2018-03-21","kind":"exercise","acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested in three equal annual installments commencing November 4, 2011 and ending November 4, 2013."}],"balance_after":5500,"derivative":{"exercise_price":3.51,"expiration_date":"2020-11-04","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001562180-18-001700","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001700/primarydocument.xml","form_type":"4"}},{"id":3986559,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-21T17:11:17.000Z","date":"2018-03-21","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three equal annual installments commencing November 1, 2009 and ending November 1, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2018-12-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001562180-18-001700","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001700/primarydocument.xml","form_type":"4"}},{"id":3986558,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-21T17:11:17.000Z","date":"2018-03-21","kind":"sale","acquired":false,"shares":21500,"price":16.76,"value":360340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-001700","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001700/primarydocument.xml","form_type":"4"}},{"id":3986557,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-21T17:11:17.000Z","date":"2018-03-21","kind":"exercise","acquired":true,"shares":14500,"price":3.51,"value":50895.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-001700","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001700/primarydocument.xml","form_type":"4"}},{"id":3986556,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-21T17:11:17.000Z","date":"2018-03-21","kind":"exercise","acquired":true,"shares":7000,"price":3.37,"value":23590.0,"ownership":{"direct":true},"balance_after":26297,"source":{"system":"sec-edgar","filing":"0001562180-18-001700","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001700/primarydocument.xml","form_type":"4"}},{"id":4011102,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-06T21:32:01.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":6086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock award granted to the Reporting Person under the Issuer's 2012 Omnibus Incentive Plan, as amended and restated.  The restricted stock vests on February 15, 2019, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":20875,"source":{"system":"sec-edgar","filing":"0000904454-18-000225","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445418000225/edgar.xml","form_type":"4"}},{"id":4037446,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-23T16:35:58.000Z","date":"2018-02-21","kind":"exercise","acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.46,"exercise_date":"2012-10-26","expiration_date":"2021-10-26","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001562180-18-001195","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001195/primarydocument.xml","form_type":"4"}},{"id":4037445,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-23T16:35:58.000Z","date":"2018-02-21","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested in three equal annual installments commencing November 1, 2009 and ending November 1, 2011."}],"balance_after":7000,"derivative":{"exercise_price":3.37,"expiration_date":"2018-12-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001562180-18-001195","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001195/primarydocument.xml","form_type":"4"}},{"id":4037444,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T16:35:58.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":21500,"price":17.16,"value":368940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-001195","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001195/primarydocument.xml","form_type":"4"}},{"id":4037443,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T16:35:58.000Z","date":"2018-02-21","kind":"exercise","acquired":true,"shares":8000,"price":3.37,"value":26960.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-001195","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001195/primarydocument.xml","form_type":"4"}},{"id":4037442,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-23T16:35:58.000Z","date":"2018-02-21","kind":"exercise","acquired":true,"shares":13500,"price":2.46,"value":33210.0,"ownership":{"direct":true},"balance_after":32797,"source":{"system":"sec-edgar","filing":"0001562180-18-001195","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001195/primarydocument.xml","form_type":"4"}},{"id":4098111,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-17T17:00:01.000Z","date":"2018-01-17","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vested in three equal annual installments commencing November 1, 2009 and ending November 1, 2011."}],"balance_after":0,"derivative":{"exercise_price":1.74,"expiration_date":"2019-10-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-000334","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018000334/primarydocument.xml","form_type":"4"}},{"id":4098110,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-17T17:00:01.000Z","date":"2018-01-17","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13500,"derivative":{"exercise_price":2.46,"exercise_date":"2012-10-26","expiration_date":"2021-10-26","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001562180-18-000334","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018000334/primarydocument.xml","form_type":"4"}},{"id":4098109,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-17T17:00:01.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":21500,"price":12.94,"value":278210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-18-000334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018000334/primarydocument.xml","form_type":"4"}},{"id":4098108,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-17T17:00:01.000Z","date":"2018-01-17","kind":"exercise","acquired":true,"shares":6500,"price":2.46,"value":15990.0,"ownership":{"direct":true},"balance_after":40797,"source":{"system":"sec-edgar","filing":"0001562180-18-000334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018000334/primarydocument.xml","form_type":"4"}},{"id":4098107,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-17T17:00:01.000Z","date":"2018-01-17","kind":"exercise","acquired":true,"shares":15000,"price":1.74,"value":26100.0,"ownership":{"direct":true},"balance_after":34297,"source":{"system":"sec-edgar","filing":"0001562180-18-000334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018000334/primarydocument.xml","form_type":"4"}},{"id":4166058,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T16:39:34.000Z","date":"2017-11-13","kind":"disposition_to_issuer","acquired":false,"shares":1035,"price":10.9,"value":11281.5,"ownership":{"direct":true},"balance_after":19297,"source":{"system":"sec-edgar","filing":"0001562180-17-003550","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003550/primarydocument.xml","form_type":"4"}},{"id":4179595,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-10-27T16:36:26.000Z","date":"2017-10-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs awarded to the reporting person on October 27, 2016 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 27, 2017."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-10-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-17-003348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003348/primarydocument.xml","form_type":"4"}},{"id":4179594,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-10-27T16:36:26.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 26, 2018, subject to continued service on Array's board of directors."}],"balance_after":5000,"derivative":{"exercise_price":0,"exercise_date":"2018-10-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-17-003348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003348/primarydocument.xml","form_type":"4"}},{"id":4179593,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-27T16:36:26.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":10.47,"exercise_date":"2018-10-26","expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-17-003348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003348/primarydocument.xml","form_type":"4"}},{"id":4179592,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-27T16:36:26.000Z","date":"2017-10-27","kind":"exercise","acquired":true,"shares":5000,"price":10.47,"value":52350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by the Issuer on October 27, 2016 as a result of the vesting of all such RSUs."}],"balance_after":20332,"source":{"system":"sec-edgar","filing":"0001562180-17-003348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003348/primarydocument.xml","form_type":"4"}},{"id":4199257,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-09-29T18:23:07.000Z","date":"2017-09-29","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is reporting the exercise by the reporting person of an option scheduled to expire on November 1, 2017 and the sale of a portion of the option shares to satisfy payment of the option exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 3 equal annual installments beginning on November 1, 2008."}],"balance_after":0,"derivative":{"exercise_price":10.58,"exercise_date":"2010-11-01","expiration_date":"2017-11-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-17-003065","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003065/primarydocument.xml","form_type":"4"}},{"id":4199256,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T18:23:07.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":39928,"price":12.36,"value":493510.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":15332,"source":{"system":"sec-edgar","filing":"0001562180-17-003065","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003065/primarydocument.xml","form_type":"4"}},{"id":4199255,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T18:23:07.000Z","date":"2017-09-29","kind":"exercise","acquired":true,"shares":45000,"price":10.58,"value":476100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is reporting the exercise by the reporting person of an option scheduled to expire on November 1, 2017 and the sale of a portion of the option shares to satisfy payment of the option exercise price."}],"balance_after":55260,"source":{"system":"sec-edgar","filing":"0001562180-17-003065","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003065/primarydocument.xml","form_type":"4"}},{"id":4304821,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-25T21:56:10.000Z","date":"2017-05-23","kind":"sale","acquired":false,"shares":2000,"price":60.01,"value":120020.0,"ownership":{"direct":true},"balance_after":14789,"source":{"system":"sec-edgar","filing":"0000904454-17-000396","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000396/edgar.xml","form_type":"4"}},{"id":4352604,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-13T20:16:50.000Z","date":"2017-04-11","kind":"sale","acquired":false,"shares":962,"price":50.85,"value":48917.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":16789,"source":{"system":"sec-edgar","filing":"0000904454-17-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000309/edgar.xml","form_type":"4"}},{"id":4382384,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T20:34:31.000Z","date":"2017-03-14","kind":"sale","acquired":false,"shares":1000,"price":46.05,"value":46050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":17751,"source":{"system":"sec-edgar","filing":"0000904454-17-000255","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000255/edgar.xml","form_type":"4"}},{"id":4397493,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-07T21:16:28.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":2835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Issuer's 2012 Omnibus Incentive Plan, as amended and restated. Each restricted stock unit represents the contingent right to receive one share of Common Stock. The restricted stock units vest on February 15, 2018, provided that the Reporting Person remains in continuous service with the Issuer through the vesting date."}],"balance_after":18751,"source":{"system":"sec-edgar","filing":"0000904454-17-000217","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000217/edgar.xml","form_type":"4"}},{"id":4442726,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-16T23:00:33.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":1000,"price":45.47,"value":45470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":15916,"source":{"system":"sec-edgar","filing":"0000904454-17-000201","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000201/edgar.xml","form_type":"4"}},{"id":4486614,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T21:55:48.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":1000,"price":46.83,"value":46830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":16916,"source":{"system":"sec-edgar","filing":"0000904454-17-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445417000057/edgar.xml","form_type":"4"}},{"id":4520578,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-15T22:32:08.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":1000,"price":49.13,"value":49130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":17916,"source":{"system":"sec-edgar","filing":"0000904454-16-001611","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445416001611/edgar.xml","form_type":"4"}},{"id":4550468,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T21:24:42.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":1000,"price":40.69,"value":40690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":18916,"source":{"system":"sec-edgar","filing":"0000904454-16-001578","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445416001578/edgar.xml","form_type":"4"}},{"id":4572129,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-10-31T19:46:25.000Z","date":"2016-10-29","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs awarded to the reporting person on October 29, 2015 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 29, 2016."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-10-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-16-003303","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218016003303/primarydocument.xml","form_type":"4"}},{"id":4572128,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-31T19:46:25.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":5.95,"exercise_date":"2017-10-27","expiration_date":"2026-10-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-16-003303","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218016003303/primarydocument.xml","form_type":"4"}},{"id":4572127,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-10-31T19:46:25.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 27, 2017, subject to continued service on Array's board of directors."}],"balance_after":5000,"derivative":{"exercise_price":0,"exercise_date":"2017-10-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-16-003303","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218016003303/primarydocument.xml","form_type":"4"}},{"id":4572126,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T19:46:25.000Z","date":"2016-10-29","kind":"exercise","acquired":true,"shares":5000,"price":5.83,"value":29150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by the Issuer on October 29, 2015 as a results of the vesting of all such RSUs."}],"balance_after":10260,"source":{"system":"sec-edgar","filing":"0001562180-16-003303","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218016003303/primarydocument.xml","form_type":"4"}},{"id":4580148,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-13T21:18:03.000Z","date":"2016-10-11","kind":"sale","acquired":false,"shares":1000,"price":42.17,"value":42170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":19916,"source":{"system":"sec-edgar","filing":"0000904454-16-001496","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445416001496/edgar.xml","form_type":"4"}},{"id":4602556,"issuer":{"id":3267,"kind":"organization","name":"MACOM Technology Solutions Holdings, Inc.","symbol":"MTSI"},"owners":[{"id":129386,"kind":"person","name":"VAN LUNSEN GIL J","position":1,"cik":"0001205014","reported_name":"VAN LUNSEN GIL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-15T21:23:14.000Z","date":"2016-09-13","kind":"sale","acquired":false,"shares":1000,"price":41.06,"value":41060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":20916,"source":{"system":"sec-edgar","filing":"0000904454-16-001443","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493594/000090445416001443/edgar.xml","form_type":"4"}}]}